Lapam Capital

Total investments

28

Average round size

28M

Portfolio companies

26

Lead investments

7

Follow on index

0.07

Exits

1

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsDeliveryMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharmaClinical Trials

Summary

The main office of represented VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.

Among the most popular fund investment industries, there are Clinical Trials, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight Connect Biopharmaceuticals, Stemirna Therapeutics, Asieris Pharmaceuticals. The fund has exact preference in some founders of portfolio startups.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Lapam Capital, startups are often financed by TF Capital, Qiming Venture Partners, XinYue Equity. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Qiming Venture Partners, Zhongguancun VC Development Center. In the next rounds fund is usually obtained by Qiming Venture Partners, Northern Light Venture Capital, Cowin Capital.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2017.

Show more

Investments analytics

Analytics

Total investments
28
Lead investments
7
Exits
1
Follow on index
0.07
Investments by industry
  • Biotechnology (21)
  • Pharmaceutical (12)
  • Health Care (10)
  • Medical (9)
  • Biopharma (5)
  • Show 11 more
Investments by region
  • China (24)
  • United States (3)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Group Appearance index
0.93

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Leads Biolabs 08 Oct 2021 Biotechnology, Health Care, Pharmaceutical Late Stage Venture 100M Nanjing, Jiangsu, China
Rapafusyn Pharmaceuticals 20 Jun 2024 Early Stage Venture 28M United States, Maryland, Baltimore

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.